TY - JOUR T1 - ClinGen Variant Curation Interface: A Variant Classification Platform for the Application of Evidence Criteria from ACMG/AMP Guidelines JF - medRxiv DO - 10.1101/2021.02.12.21251663 SP - 2021.02.12.21251663 AU - Christine G. Preston AU - Matt W. Wright AU - Rao Madhavrao AU - Steven M. Harrison AU - Jennifer L. Goldstein AU - Xi Luo AU - Hannah Wand AU - Bryan Wulf AU - Gloria Cheung AU - Mark E. Mandell AU - Howard Tong AU - Shaung Cheng AU - Michael A. Iacocca AU - Arturo Lopez Pineda AU - Alice B. Popejoy AU - Karen Dalton AU - Jimmy Zhen AU - Selina S. Dwight AU - Lawrence Babb AU - Marina DiStefano AU - Julianne M. O’Daniel AU - Kristy Lee AU - Erin R. Riggs AU - Diane B. Zastrow AU - Jessica L. Mester AU - Deborah I. Ritter AU - Ronak Y. Patel AU - Sai Lakshmi Subramanian AU - Aleks Milosavljevic AU - Jonathan S. Berg AU - Heidi L. Rehm AU - Sharon E. Plon AU - J. Michael Cherry AU - Carlos D. Bustamante AU - Helio A. Costa AU - on behalf of the Clinical Genome (ClinGen) Resource Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/18/2021.02.12.21251663.abstract N2 - Background Identification of clinically significant genetic alterations involved in human disease has been dramatically accelerated by developments in next-generation sequencing technologies. However, the infrastructure and accessible comprehensive curation tools necessary for analyzing an individual patient genome and interpreting genetic variants to inform healthcare management have been lacking.Results Here we present the ClinGen Variant Curation Interface (VCI), a global open-source variant classification platform for supporting the application of evidence criteria and classification of variants based on the ACMG/AMP variant classification guidelines. The VCI is among a suite of tools developed by the NIH-funded Clinical Genome Resource (ClinGen) Consortium, and supports an FDA-recognized human variant curation process. Essential to this is the ability to enable collaboration and peer review across ClinGen Expert Panels supporting users in comprehensively identifying, annotating, and sharing relevant evidence while making variant pathogenicity assertions. To facilitate evidence-based improvements in human variant classification, the VCI is publicly available to the genomics community and is available at https://curation.clinicalgenome.org. Navigation workflows support users providing guidance to comprehensively apply the ACMG/AMP evidence criteria and document provenance for asserting variant classifications.Conclusion The VCI offers a central platform for clinical variant classification that fills a gap in the learning healthcare system, and facilitates widespread adoption of standards for clinical curation.Competing Interest StatementDisclosure: S.E.P. is a member of the Baylor Genetics Scientific Advisory Panel. A.M. is an employee of Baylor College of Medicine (BCM) and performs integration consulting services for BCM-developed software including Genboree through IP Genesis Inc. C.D.B. is on the scientific advisory boards (SAB) of AncestryDNA, Arc Bio LLC, Etalon DX, Liberty Biosecurity, and Personalis. C.D.B. is on the board of EdenRoc Sciences LLC. C.D.B. is also a founder and SAB chair of ARCBio. J.L.M. is an employee of GeneDx/BioReference Laboratories, Inc./OPKO Health and has a salary as the only disclosure. None of these entities played a role in the design, execution, interpretation, or presentation of this study.Funding StatementSources of support: This research was funded by grants from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (U41HG009649, U01HG007436, U41HG006834, U01HG007434, U41HG009650).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB approval not necessaryAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code for the VCI including front-end, back-end, database schemas, analysis pipelines, and user interfaces are freely available under MIT Open Source licenses via the GitHub repositories (https://github.com/ClinGen/ and https://github.com/ClinGen/clincoded/).https://github.com/ClinGen/https://github.com/ClinGen/clincoded/ ER -